FUNGIZONE

This brand name is authorized in Canada, Estonia, Finland, France, Hong Kong SAR China, Ireland, Japan, Lithuania, Malta, Netherlands, Poland, South Africa, Tunisia, Turkey, UK.

Active ingredients

The drug FUNGIZONE contains one active pharmaceutical ingredient (API):

1
UNII 7XU7A7DROE - AMPHOTERICIN B
 

Amphotericin B is a macrocyclic, polyene antifungal antibiotic produced by Streptomyces nodosus. The molecule is thought to act by binding to sterols in the fungal cell membrane, with a resulting change in membrane permeability, allowing leakage of a variety of small molecules.

 
Read more about Amphotericin B

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A01AB04 Amphotericin B A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AB Antiinfectives and antiseptics for local oral treatment
Discover more medicines within A01AB04
A07AA07 Amphotericin B A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07A Intestinal antiinfectives → A07AA Antibiotics
Discover more medicines within A07AA07
G01AA03 Amphotericin B G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AA Antibiotics
Discover more medicines within G01AA03
J02AA01 Amphotericin B J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AA Antibiotics
Discover more medicines within J02AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
CA Health Products and Food Branch 00029149
EE Ravimiamet 1095689, 1552700, 1619940
FI Lääkealan turvallisuus- ja kehittämiskeskus 436444
FR Base de données publique des médicaments 63709997, 64346723, 68211089
GB Medicines & Healthcare Products Regulatory Agency 47028
HK Department of Health Drug Office 00037
JP 医薬品医療機器総合機構 6173001Q1047, 6173400D1035
LT Valstybinė vaistų kontrolės tarnyba 1090649
MT Medicines Authority AA1456/00501, AA565/26102
NL Z-Index G-Standaard 12121614
NL Z-Index G-Standaard, PRK 1058, 5436
PL Rejestru Produktów Leczniczych 100281935, 100418877
TN Direction de la Pharmacie et du Médicament 6400021, 6400023H
TR İlaç ve Tıbbi Cihaz Kurumu 8682340179022
ZA Health Products Regulatory Authority A/20.1.7/0150

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.